NEWS & EVENTS
Several weeks after winning the Nobel Prize for pioneering microscope methods developed while at the NIH, Eric Betzig published a new technique in the journal Science that allows observation of living cellular processes at groundbreaking resolution and speed. Read more at www.washingtonpost.com.
A research team including NIBIB-funded researchers has developed a system capable of efficiently delivering delicate therapeutic molecules in vivo. In response to temperature changes, the thermosponge nanoparticles expand to absorb therapeutic but delicate molecules such as proteins, contract to transport them to disease targets, and expand to release their therapeutic payload at the site of disease. Read more at Science Daily.
NIBIB's Bionic Man is featured in the fall issue of NIH's Medline Plus Magazine. The bionic man highlights fourteen technologies being developed by NIBIB-supported researchers, including advances in prostheses, brain-computer interfaces, and vaccine delivery. Read more at www.nlm.nih.gov/medlineplus/magazine.
NIBIB researchers have teamed-up with commercial partners to develop their "electronic skin" that looks like a tattoo but monitors and transmits data about the health status of the wearer. Applications include monitoring the movements of Parkinson's patients, remotely keeping tabs on your child's temperature, and even receiving an email from your wearable patch recommending the best skin care products based on your skin hydration and perspiration levels. Read more in the New York Times.
A research team including NIBIB-funded scientists isolated circulating tumor cells (CTCs) in a mouse model of pancreatic cancer. Molecular analysis of the CTCs revealed distinct patterns of gene expression that were different from the primary pancreatic tumor. The surprising results identify potential new molecular targets that could lead to improved treatments for this deadly cancer. Read more in Bioscience Technology
Case Western Reserve University’s synchrotron facility at Brookhaven National Laboratory is on its way to becoming the No. 1 beamline facility for biology in the world by early 2016, thanks to a jumpstart grant of $4.6 million from NIBIB. Read more at News Medical.